PL1979321T3 - Nowe pirydynyloaminoalkileno- i pirydynyloksyalkileno- cyklopropanoaminy, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne - Google Patents
Nowe pirydynyloaminoalkileno- i pirydynyloksyalkileno- cyklopropanoaminy, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczneInfo
- Publication number
- PL1979321T3 PL1979321T3 PL07730888T PL07730888T PL1979321T3 PL 1979321 T3 PL1979321 T3 PL 1979321T3 PL 07730888 T PL07730888 T PL 07730888T PL 07730888 T PL07730888 T PL 07730888T PL 1979321 T3 PL1979321 T3 PL 1979321T3
- Authority
- PL
- Poland
- Prior art keywords
- pyridinyloxyalkylene
- pyridinylaminoalkylene
- cyclopropanamines
- novel
- preparation
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0600784A FR2896800B1 (fr) | 2006-01-30 | 2006-01-30 | Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| EP07730888A EP1979321B9 (fr) | 2006-01-30 | 2007-01-30 | Nouveaux composes pyridinylaminoalkylene- et pyridinyloxyalkylene- cyclopropanamines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2007/000170 WO2007085750A1 (fr) | 2006-01-30 | 2007-01-30 | Nouveaux composes pyridinylaminoalkylene- et pyridinyloxyalkylene- cyclopropanamines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1979321T3 true PL1979321T3 (pl) | 2009-10-30 |
Family
ID=37102591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07730888T PL1979321T3 (pl) | 2006-01-30 | 2007-01-30 | Nowe pirydynyloaminoalkileno- i pirydynyloksyalkileno- cyklopropanoaminy, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20100317698A1 (pl) |
| EP (1) | EP1979321B9 (pl) |
| JP (1) | JP2009525311A (pl) |
| KR (1) | KR101050910B1 (pl) |
| CN (1) | CN101374814B (pl) |
| AR (1) | AR059221A1 (pl) |
| AT (1) | ATE437857T1 (pl) |
| AU (1) | AU2007209235B2 (pl) |
| BR (1) | BRPI0710443A2 (pl) |
| CA (1) | CA2640482C (pl) |
| CY (1) | CY1109477T1 (pl) |
| DE (1) | DE602007001779D1 (pl) |
| DK (1) | DK1979321T3 (pl) |
| EA (1) | EA015227B1 (pl) |
| ES (1) | ES2330899T3 (pl) |
| FR (1) | FR2896800B1 (pl) |
| GE (1) | GEP20105090B (pl) |
| HR (1) | HRP20090523T1 (pl) |
| MA (1) | MA30222B1 (pl) |
| MY (1) | MY149068A (pl) |
| NO (1) | NO20083753L (pl) |
| PL (1) | PL1979321T3 (pl) |
| PT (1) | PT1979321E (pl) |
| RS (1) | RS51065B (pl) |
| SI (1) | SI1979321T1 (pl) |
| UA (1) | UA88116C2 (pl) |
| WO (1) | WO2007085750A1 (pl) |
| ZA (1) | ZA200806399B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011003306A (es) * | 2008-10-14 | 2011-09-01 | Psychogenics Inc | Ligandos nicotinicos de receptor de acetilcolina y los usos de los mismos. |
| EP2714041B1 (en) * | 2011-05-24 | 2016-10-19 | Merck Sharp & Dohme Corp. | Aryloxymethyl cyclopropane derivatives as pde10 inhibitors |
| CN112125901A (zh) * | 2014-09-05 | 2020-12-25 | 赛尔基因昆蒂赛尔研究公司 | 赖氨酸特异性脱甲基酶-1的抑制剂 |
| US20180311238A1 (en) * | 2017-04-28 | 2018-11-01 | Saniona A/S | Selective Agonist Of a6 Containing nAChRs |
| CN110483392A (zh) * | 2018-05-14 | 2019-11-22 | 上海海和药物研究开发有限公司 | 合成n-保护的喹啉-7-基氧基甲基环丙基胺衍生物的方法及合成中间体 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003501416A (ja) * | 1999-06-07 | 2003-01-14 | ターガセプト,インコーポレイテッド | 医薬組成物およびその使用法 |
| JP2001261652A (ja) * | 2000-03-21 | 2001-09-26 | Suntory Ltd | 二置換イミノヘテロサイクリック化合物 |
| FR2810664B1 (fr) * | 2000-06-27 | 2004-12-24 | Adir | Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US7098331B2 (en) * | 2003-03-05 | 2006-08-29 | Targacept, Inc. | Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| FR2889188B1 (fr) * | 2005-07-28 | 2007-09-07 | Servier Lab | Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent |
| FR2889187B1 (fr) * | 2005-07-28 | 2007-09-07 | Servier Lab | Nouveaux composes 1,1-pyridinyloxycyclopropanamines polysusbstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2006
- 2006-01-30 FR FR0600784A patent/FR2896800B1/fr not_active Expired - Fee Related
-
2007
- 2007-01-29 AR ARP070100362A patent/AR059221A1/es unknown
- 2007-01-30 GE GEAP200710875A patent/GEP20105090B/en unknown
- 2007-01-30 KR KR1020087021424A patent/KR101050910B1/ko not_active Expired - Fee Related
- 2007-01-30 EP EP07730888A patent/EP1979321B9/fr active Active
- 2007-01-30 AU AU2007209235A patent/AU2007209235B2/en not_active Ceased
- 2007-01-30 BR BRPI0710443-0A patent/BRPI0710443A2/pt not_active IP Right Cessation
- 2007-01-30 DK DK07730888T patent/DK1979321T3/da active
- 2007-01-30 AT AT07730888T patent/ATE437857T1/de active
- 2007-01-30 PL PL07730888T patent/PL1979321T3/pl unknown
- 2007-01-30 EA EA200801681A patent/EA015227B1/ru not_active IP Right Cessation
- 2007-01-30 PT PT07730888T patent/PT1979321E/pt unknown
- 2007-01-30 CN CN2007800039160A patent/CN101374814B/zh not_active Expired - Fee Related
- 2007-01-30 UA UAA200810613A patent/UA88116C2/ru unknown
- 2007-01-30 WO PCT/FR2007/000170 patent/WO2007085750A1/fr not_active Ceased
- 2007-01-30 JP JP2008552845A patent/JP2009525311A/ja not_active Withdrawn
- 2007-01-30 ES ES07730888T patent/ES2330899T3/es active Active
- 2007-01-30 RS RSP-2009/0450A patent/RS51065B/sr unknown
- 2007-01-30 MY MYPI20082681A patent/MY149068A/en unknown
- 2007-01-30 DE DE602007001779T patent/DE602007001779D1/de active Active
- 2007-01-30 CA CA2640482A patent/CA2640482C/fr not_active Expired - Fee Related
- 2007-01-30 ZA ZA200806399A patent/ZA200806399B/xx unknown
- 2007-01-30 US US12/223,311 patent/US20100317698A1/en not_active Abandoned
- 2007-01-30 HR HR20090523T patent/HRP20090523T1/hr unknown
- 2007-01-30 SI SI200730068T patent/SI1979321T1/sl unknown
-
2008
- 2008-08-19 MA MA31181A patent/MA30222B1/fr unknown
- 2008-09-01 NO NO20083753A patent/NO20083753L/no not_active Application Discontinuation
-
2009
- 2009-10-07 CY CY20091101033T patent/CY1109477T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
| DK3872058T3 (en) | Process for the preparation of 2,3,3,3 tetrahydrofluoropropene | |
| IL195488A (en) | Compounds, pharmaceuticals containing them and their uses | |
| ZA200805939B (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
| SI2036892T1 (sl) | Derivati tetrahidro h benzazepinov postopek za njihovo pripravo in farmacevtski sestavkiki jih vsebujejo | |
| SI1752443T1 (sl) | Nova kristalinična oblika V agomelatina, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo | |
| IL193339A0 (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
| IL193341A0 (en) | Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments | |
| IL184562A (en) | Polymorph ivandront a, a process for its preparation and pharmaceutical preparations containing it | |
| PT2210872T (pt) | Nova forma cristalina iii de agomelatina, processo para a sua preparação e composições farmacêuticas que a contêm | |
| HUP0401522A2 (en) | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation | |
| TWI315305B (en) | Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof | |
| EP1871363A4 (en) | COMBINED STAGE PROCESS FOR PHARMACEUTICAL COMPOSITIONS | |
| PT2231598E (pt) | Novos derivados diazéniodiolato, processo para a sua preparação e as composições farmacêuticas que os contenham | |
| ZA200806399B (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
| ZA200902414B (en) | Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| PL1707564T3 (pl) | Pochodne indanylopiperazyn, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne | |
| ZA200603810B (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200902413B (en) | Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| IL192963A0 (en) | Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same | |
| ZA200808768B (en) | Pharmaceutical composition containing the NMB0606 protein | |
| IL189177A0 (en) | Process for producing carcosporamide and pharmaceutical compositions containing cercosporamide | |
| ZA200603809B (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200805656B (en) | Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds | |
| ZA200800833B (en) | New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them |